SPIA
LEGN icon

Steward Partners Investment Advisory’s Legend Biotech LEGN Stock Holding History

Steward Partners Investment Advisory’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$4.35K – 4509
2025
Q4 		$4.35K Hold
200
– – ﹤0.01% 3735
2025
Q3 		$6.52K Buy
+200
New +$7.38K ﹤0.01% 3564

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Steward Partners Investment Advisory's LEGN Position: Q1 2026 in Review

Steward Partners Investment Advisory sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 200 shares — an estimated $4.35K sold.

Steward Partners Investment Advisory first reported a position in LEGN in Q3 2025 and held it in 2 quarters. The position peaked at $6.52K in Q3 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Steward Partners Investment Advisory reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 200 Legend Biotech shares in Q1 2026, an estimated $4.35K.
  • Steward Partners Investment Advisory first reported a position in Legend Biotech in Q3 2025 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Legend Biotech position peaked at $6.52K in Q3 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.